StockData
Universal Health Realty Income Trust logo

Universal Health Realty Income Trust (UHT) stock analysis

UHTNYSEReal Estate Investment TrustsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 6, 2026Score 16/303% below fair value
$39.03+0.27 (+0.70%)

Close on Nov 11, 2026Market cap $542.47MP/E 26.9Yield 7.58%

StockData Score

Prices as of Nov 11, 2026How the score works

Value3Growth1Performance3Health5Dividend4

Solid16 of 30 checks passed

Universal Health Realty Income Trust passes 16 of the 30 checks behind our score; 4 could not be run for lack of data and count as not passed. Each dot in the shape is one check — hover it for the numbers.

Valuation
3/6
Growth
1/6
Past performance
3/6
Financial health
5/6
Dividend
4/6

What stands out

  • Trading below fair value

    The share price of $39.03 is below our fair value estimate of $40.34.

  • Return on capital over 10%

    Return on invested capital was 19.8%, above the 10% that usually covers the cost of capital.

  • No debt

    Universal Health Realty Income Trust has no borrowings on its latest balance sheet.

  • Earnings growth accelerating

    Net income grew 12.4% over the last twelve months, against a 5-year average of -2.0% a year.

What to watch

  • Margin of safety under 20%

    The price is 3.3% below fair value, less than the 20% cushion we look for.

  • Return on equity under 15%

    Return on equity was 13.5% over the last twelve months and averaged 18.5% over five years; we look for 15% on both.

  • Earnings shrank over 5 years

    Net income shrank 2.0% a year on average over the last five fiscal years.

  • Revenue growing under 10% a year

    Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.

Valuation3/6
  • P/E below its 5-year median

    Universal Health Realty Income Trust's P/E of 26.9 is below its own 5-year median of 31.6.

  • P/E above the industry

    Universal Health Realty Income Trust's P/E of 26.9 is above the Miscellaneous Investing median of 26.3.

  • EV/EBITDA below its 5-year median

    Universal Health Realty Income Trust's EV/EBITDA of 8.4 is below its 5-year median of 9.3.

  • P/B above the industry

    Universal Health Realty Income Trust's price-to-book of 3.89 is above the Miscellaneous Investing median of 1.20.

  • Trading below fair value

    The share price of $39.03 is below our fair value estimate of $40.34.

  • Margin of safety under 20%

    The price is 3.3% below fair value, less than the 20% cushion we look for.

Growth1/6
  • Revenue growing under 10% a year

    Revenue grew 3.1% a year over the last three fiscal years, short of the 10% we look for.

  • EPS growing under 10% a year

    Diluted EPS grew -6.0% a year over the last three fiscal years.

  • Earnings growth accelerating

    Net income grew 12.4% over the last twelve months, against a 5-year average of -2.0% a year.

  • Growing slower than the industry

    Revenue grew -0.0% over the last twelve months; the Miscellaneous Investing median is 4.6%.

  • Company guidance

    No outlook found in earnings releases from the last twelve months.

  • Gross margin trend

    This company does not report gross profit.

Past performance3/6
  • Return on equity under 15%

    Return on equity was 13.5% over the last twelve months and averaged 18.5% over five years; we look for 15% on both.

  • Return on capital over 10%

    Return on invested capital was 19.8%, above the 10% that usually covers the cost of capital.

  • Return on equity above the industry

    Universal Health Realty Income Trust's return on equity of 13.5% is above the Miscellaneous Investing median of 3.1%.

  • Earnings shrank over 5 years

    Net income shrank 2.0% a year on average over the last five fiscal years.

  • Net margin below its 5-year average

    Net margin was 20.3% over the last twelve months, against a 5-year average of 41.2%.

  • Net margin above the industry

    Universal Health Realty Income Trust's net margin of 20.3% is above the Miscellaneous Investing median of 10.3%.

Financial health5/6
  • No debt

    Universal Health Realty Income Trust has no borrowings on its latest balance sheet.

  • Debt not rising

    With no debt today, leverage cannot have risen.

  • Debt covered by cash flow

    There is no debt to cover.

  • Interest well covered

    No meaningful interest expense to cover.

  • Short-term liquidity

    The balance sheet is not split into current and non-current items.

  • Low bankruptcy risk

    The Altman Z-score is 3.28; above 3 is the safe zone and below 1.8 the distress zone.

Dividend4/6
  • Pays a dividend

    Universal Health Realty Income Trust paid dividends worth 7.7% of the share price over the last twelve months.

  • Yield above Treasuries

    The 7.7% yield is above the 4.4% on a 1-year Treasury.

  • Yield in the top quarter

    The top quarter of US dividend payers yield 3.8% or more; Universal Health Realty Income Trust yields 7.7%.

  • Dividend not cut

    The dividend per share has not fallen by more than 10% in any of the last 10 fiscal years.

  • Not covered by earnings

    Dividends take 206% of net income, leaving little room.

  • Cash-flow cover

    Needs dividends paid and free cash flow.

Scores of similar companies

Our estimate per share

$40.34

The share price is 3% below this estimate.

20%+ below
Near fair value
20%+ above
$39.03Price
MethodMultiple usedOwn 5Y medianIndustry medianValue per shareWeight
P/E29.0×31.6×26.3×$42.0540%
EV/EBITDA9.4×9.3×9.5×$43.4835%
P/B2.1×3.1×1.2×$21.5410%
Earnings power7.7% cost of equity––$41.0315%
Fair value$40.34100%

Valuation over time

Using the earnings and balance sheet published at each date, not today's.

  • P/E at month end
  • Own 5-year median 31.6
  • Miscellaneous Investing median 26.3

An estimate from reported numbers and market multiples, not a price target or investment advice. It can be far off for companies whose profits are about to change sharply.

Market risk

From the past year of daily prices.

Liquidity

Medium risk

Average value traded per day
$5.23M
Value traded per 1% price move
$4.41M

Downside

Low risk

Typical loss in a bad month
9.6%
Volatility (annualized)
23%
Sharpe ratio, 1 year
-0.19
Beta to the S&P 500 (5Y)
0.56

Typical bad-month loss, week by week

25%: high

Margins

Share of revenue, fiscal years 2011 to 2025

Operating margin

35.0%+1.7 pts over 5 years

Net margin

17.8%−7.2 pts over 5 years

See a number that looks wrong?